GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Additional Paid-In Capital

Exact Therapeutics AS (OSL:EXTX) Additional Paid-In Capital : kr44.97 Mil(As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Additional Paid-In Capital?


Exact Therapeutics AS's quarterly additional paid-in capital declined from Dec. 2022 (kr105.13 Mil) to Jun. 2023 (kr67.73 Mil) but then stayed the same from Jun. 2023 (kr67.73 Mil) to Dec. 2023 (kr44.97 Mil).

Exact Therapeutics AS's annual additional paid-in capital declined from Dec. 2021 (kr227.64 Mil) to Dec. 2022 (kr105.13 Mil) and declined from Dec. 2022 (kr105.13 Mil) to Dec. 2023 (kr44.97 Mil).

Exact Therapeutics AS Additional Paid-In Capital Historical Data

The historical data trend for Exact Therapeutics AS's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Additional Paid-In Capital Chart

Exact Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 72.44 222.99 227.64 105.13 44.97

Exact Therapeutics AS Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 227.64 77.74 105.13 67.73 44.97

Exact Therapeutics AS Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Exact Therapeutics AS Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Additional Paid-In Capital
Comparable Companies
OSL:CIRCA OSL:TRMED OSL:LYTIX OSL:BGBIO OSL:ABS OSL:PCIB OSL:ABTEC OSL:SOFTX OSL:CRNA OSL:HBC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Ostre Aker vei 19, Oslo, NOR, 0581
Website
https://www.exact-tx.com
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines